Adaptimmune Therapeutics Plc
ADAP
Revenue
3.22M
▼-37.68M▼-92.12%
3 Months ChangeAssets
245.96M
▼-71.47M▼-22.52%
3 Months ChangeLiabilities
234.11M
▼-3.33M▼-1.40%
3 Months ChangeFree Cash Flow
-32.05M
▲7.58M▲19.13%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-11-01
Form 8-K
ID: 0001558370-24-014148
2024-09-23
Form 8-K
ID: 0001558370-24-012960
2024-08-12
Form 10-Q
ID: 0001558370-24-011798
2024-08-12
Form 8-K
ID: 0001558370-24-011793
2024-08-02
Form 8-K
ID: 0001104659-24-085098
2024-07-16
Form 8-K
ID: 0001558370-24-009854
2024-06-11
Form 8-K
ID: 0001558370-24-009053
2024-05-30
Form 8-K
ID: 0001558370-24-008778
2024-05-15
Form 10-Q
ID: 0001558370-24-008287
2024-05-15
Form 8-K
ID: 0001558370-24-008210